16 Comments

A cancer drug for solid tumors. Allegedly to reduce inflammation? Which interacts ( poorly? ) with chemo agents? Does it say which chemo agents specifically it interacts with? I guess my question is.. how will this kill people or maim them so that they become more profitable for Big Pharma?

Expand full comment

I am not sure. Deplete the immune system perhaps? Chemo wipes out our immune systems to fight the “bad” cells…..then we cannot fight the “cOvId infection” and they die. Totally speculative, just a stab in the dark at it. Gross isn’t it.

Expand full comment

Horrid. I’m also thinking more heart issues. I forget which chemo drug it is, red devil maybe? that is known to cause myocarditis in patients ….

Expand full comment

So the FDA is now just going to bypass testing and long term studies and give new drugs EAU status? Well that’s just a minor step up from what they have been doing since Obama passed legislation that let more drugs be fast tracked on to the market without testing and long term studies. But worry not because in about a decade the FDA will find that the drugs cause harm and they will remove them from the market.

And yes this smells awfully 'ModeRNA.'

Expand full comment

Totally off topic: I left my house to run an errand today. Before I made it a mile I counted 20 people driving alone and all masked up. I have come to believe that my fellow citizens can't reason their way out of a wet paper bag. This is what drove me to my wolfish position about the coming "crisis". I used to fancy myself a sheep dog. Now I believe I'm leaning towards behaving like a wolf. As Stabbing Westward so prophetically sang: I cannot save you. I can't even save myself.

IFRX on the NASDAQ. Hovering a wee bit above $4 / share. It has been as high as $6.10 / share this year. Do you suppose it is poised to "make a killing" once the new COVID lock down hits? Why should big pharma players be the only ones to improve their position?

Anyone have any guesses about how hard those exhibiting civil disobedience during the coming lock down will be punished? I don't believe it will be pretty. But I WILL resist and I WILL win.

Expand full comment

Does not pass the smell test at all. The elites are up to something and they are using this "company" as a cover. It will come out, nobody trusts the FDA anymore when it comes to COVID.

Expand full comment

Perhaps an another random odd fact: Surgeon Robert Bartlett who is credited with developing the ECMO machine ( rumor was, in his basement) is a professor emeritus at the University of Michigan, Ann Arbor.

Expand full comment

Well that is certainly interesting isn’t it!!!! 🤔

Expand full comment

I believe big pharma is really controlled by Black Rock and Vanguard. Just like this company. And did you know what Vivek Ramaswamy's business affiliation? He founded Roivant Sciences, a pharmaceutical company, in 2014. Just before he became a Republican Presidential Candidate, his stock skyrocketed when Blackrock and Vanguard invested into his company. They had not made a profit since it's inception. I wonder why Vivek tells the American people everything they want to hear and strongly supports all President Trump's talking points.

Expand full comment

Blackrock vanguard own everything. Viveks a good talker but not walker, too young. So no to pres warp speed and no to RFK.. Brandon’s getting replaced. So who’s turn is it?

Expand full comment

Vivek is Obama 2.0 in my opinion.

Expand full comment

Puzzling. Do you think they want to covertly, under the COVID guide, administer a stealth prophylaxis against injection-caused turbo cancer? Hardly. Puzzling.

Expand full comment

I wondered that too……is this some disguised cancer treatment?

Expand full comment

Given that they have precise data on who was injected with what, and on their health condition pre and post injection (series)... They might just treat everyone with that stuff and then find out by observation if cancer rates go down, or what kinds of cancers continue to escalate and which don't... At the same time, they would know which genetic makeup seems to respond best and least because they have (if they want) the DNA samples of most patients, either from past testing or, or and, from testing in the coming "season". They can monitor all sorts of parameters and developments should they be interested.

Expand full comment